Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'The Global Market for Point of Care Diagnostics - Major Players and Key Issues' returned 49 results - Page 1 of 3

  Sort by   
  Sorted by Rank Top-Bottom

Assessment of the Asia-Pacific In-Vitro Diagnostic (IVD) Market  
Smart Research Insights, Feb 2012, Pages: 25
Assessment of the Asia-Pacific In-Vitro Diagnostic (IVD) Market Executive Summary: The In-Vitro Diagnostics (IVD) industry endured the impact of the global recession, with key players introducing


Blood Gas And Electrolyte Analyzers - Global Strategic Business Report  
Global Industry Analysts, Inc., Jan 2011, Pages: 332
profiles 39 companies including many key and niche players such as - Abaxis, Inc. - Abbott Point-of-Care - Beckman Coulter, Inc. - Hemagen Diagnostics, Inc. - IDEXX Laboratories, Inc. - OPTI Medical


Immunoassay Systems - Global Strategic Business Report  
Global Industry Analysts, Inc., Aug 2010, Pages: 589
Sales by Leading Players (includes corresponding Graph/Chart) 2. INDUSTRY TRENDS & ISSUES - Shift Towards Point-of-Care Test Systems - Hospital and Laboratory Consolidations Drive the Market for


Genetic Testing - Global Strategic Business Report  
Global Industry Analysts, Inc., Feb 2012, Pages: 375
Genetic Testing - Global Strategic Business Report This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and


Cholesterol & Other Cardiovascular Testing - Global Strategic Business Report  
Global Industry Analysts, Inc., Feb 2011, Pages: 293
: Global Cholesterol Point-of-Care Rapid Tests Market (2009): Market Shares of Leading Players by Value Sales for Inverness Medical, Roche, Abaxis, and Others (includes


Medical Nanotechnology Markets  
TriMark Publications, Sep 2008, Pages: 183
immediate feedback of medical conditions, all point to nanotechnology as offering a new approach in healthcare. According to U.S. National Science Foundation estimates, by 2015 the annual global market for


The 2011-2016 World Outlook for Health Care Equipment and Supplies  
ICON Group International, Jan 2011, Pages: 188
health care equipment and supplies at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively


The 2011-2016 World Outlook for Veterinary Pharmaceuticals, Medicinal Premixes, and Medicated Pet Care Products Excluding Diagnostic Preparations and Pet Flea-And-Tick Products  
ICON Group International, Jan 2011, Pages: 200
, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order to estimate the latent demand


The 2011-2016 World Outlook for Blood Gas and Electrolyte Analyzers  
ICON Group International, Jan 2011, Pages: 199
electrolyte analyzers at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates


The 2011-2016 World Outlook for Blood Glucose Meters and Strips  
ICON Group International, Jan 2011, Pages: 195
at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent


Issuer Ranking: U.S. Health Care Companies, Strongest To Weakest Oct 07  
Standard & Poors, Oct 2007, Pages: 195
underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in North America & the Caribbean  
ICON Group International, Jan 2011, Pages: 37
electrolyte analyzers in North America & the Caribbean at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are


The 2011 Report on Blood Gas and Electrolyte Analyzers: World Market Segmentation by City  
ICON Group International, Jan 2011, Pages: 329
electrolyte analyzers at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in Europe  
ICON Group International, Jan 2011, Pages: 54
in Europe at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in The Middle East  
ICON Group International, Jan 2011, Pages: 36
electrolyte analyzers in the Middle East at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in Oceana  
ICON Group International, Jan 2011, Pages: 34
in Oceana at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in Asia  
ICON Group International, Jan 2011, Pages: 38
in Asia at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in Africa  
ICON Group International, Jan 2011, Pages: 56
in Africa at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in Latin America  
ICON Group International, Jan 2011, Pages: 35
electrolyte analyzers in Latin America at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively


The 2011-2016 Outlook for Blood Gas and Electrolyte Analyzers in Greater China  
ICON Group International, Jan 2011, Pages: 142
, cultural barriers to consumption, regulations, and cartel-like behavior on the part of firms. In general, however, latent demand is typically larger than actual sales in a market. For reasons discussed


Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds